Heritage Pharmaceuticals Inc. is recalling 13,805 bottles of Desmopressin Acetate Tablets 0.2mg, which were distributed by Avet Pharmaceuticals Inc. The recall was initiated because the tablets were found to be subpotent, meaning they contain less of the active medication than is required by quality standards. Consumers using these tablets should consult their healthcare provider or pharmacist to discuss their treatment and obtain a replacement, as the subpotent medication may not be effective. No injuries or medical incidents have been reported to date regarding this issue.
Because the tablets are subpotent, patients may not receive the full intended dose of desmopressin acetate. This can lead to ineffective treatment of serious conditions like diabetes insipidus or bedwetting, potentially causing symptoms to worsen or return.
You have 2 options:
Distributed by Avet Pharmaceuticals Inc. Recall #: D-0072-2023.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.